Роль рецепторов врожденного иммунитета в развитии инфекционного процесса, обусловленного Mycobacterium tuberculosis
Аннотация
Согласно данным Всемирной организации здравоохранения, ежегодно во всем мире регистрируется свыше 10 млн новых случаев туберкулеза. В Российской Федерации, по данным Федеральной службы государственной статистики, в 2017 г. на 100 тыс. населения зарегистрировано 109,8 случаев активного туберкулеза, из которых 41,3% имели запущенную форму заболевания. Повсеместная распространенность заболевания независимо от климатических условий обусловлена не только высокой выживаемостью Mycobacterium tuberculosis, но и способностью возбудителя длительно персистировать в организме человека и реактивироваться через неограниченный период времени. Итог инфицирования в значительной степени определяется иммунореактивностью самого организма-хозяина и его готовностью к развитию протективного иммунного ответа. Кроме того, уже после развития болезни состояние иммунной системы определяет и течение туберкулеза: либо в виде ограниченной формы, либо с обширным поражением легких и даже других органов, что наблюдается при генерализованной инфекции. В последние десятилетия большое внимание исследователей было направлено на изучение механизмов клеточного адаптивного иммунитета в патогенезе туберкулезной инфекции. Безусловно, адаптивный иммунитет является мощной защитой, обеспечивающей целенаправленный специфический иммунный ответ, однако в настоящее время становится понятным, что он является лишь эффекторным звеном врожденного иммунитета. Врожденный иммунитет — филогенетически более древняя, наследственно закрепленная система, основной задачей которой является обеспечение быстрой элиминации патогена и предотвращение развития инфекции на ранних стадиях, когда механизмы адаптивного иммунитета отсутствуют. Механизмы врожденного иммунитета представлены клетками, разнообразными рецепторами, молекулами и их комплексами, присутствующими на разных клетках и имеющими одинаковое предназначение. Активация врожденного иммунитета начинается с распознавания одинаковых групп молекул, присутствующих у различных патогенов, — патоген-ассоциированных молекулярных паттернов (pathogen-accociated molecular patterns — PAMPs), осуществляемого с помощью паттерн-распознающих рецепторов (pathogen recognition receptops — PRRs). В обзоре приводятся данные о роли рецепторов врожденного иммунитета в распознавании PAMPs, присущих Mycobacterium tuberculosis, в продукции иммунорегуляторных цитокинов и в активации сигнальных путей, играющих критическую роль в регуляции некроптоза, апоптоза и аутофагии инфицированных макрофагов. Рассматривается значение факторов врожденного мукозального иммунитета в реализации иммунного ответа на M. tuberculosis. Описано участие Toll-подобных и скавенджер-рецепторов, манноз-ного рецептора, DC-SIGN и других в развитии иммунитета против M. tuberculosis. Представлены данные о полиморфных вариантах генов врожденного иммунитета, формирующих предрасположенность к туберкулезу и оказывающих влияние на характер его течения.
Об авторах
А. В. ЛапштаеваРоссия
Лапштаева Анна Васильевна - доцент кафедры иммунологии, микробиологии и вирусологии.
430005, Саранск, ул. Большевистская, 68, Тел.: 8 (927) 177-35-55
Е. А. Живечкова
Россия
Ординатор кафедры госпитальной терапии № 2 лечебного факультета.
Москва
И. В. Сычев
Россия
Аспирант Медицинского института.
СаранскИ. В. Евсегнеева
Россия
Доктор медицинских наук, профессор, профессор кафедры клинической иммунологии и аллергологии.
Москва
В. В. Новиков
Доктор медицинских наук, профессор, заведующий кафедрой молекулярной биологии и иммунологии НИНГУ им. Н.И. Лобачевского; зав. лабораторией иммунохимии НГИИЭМ им. академика И.Н. Блохиной.
Нижний Новгород
Список литературы
1. Герасимов А.Н., Михеева И.В. Эпидемиологическая ситуация с туберкулезом в России — кажущееся благополучие и скрытые угрозы // Тихоокеанский медицинский журнал. 2018. № 3. С. 75—78.
2. Звонкова С.Г., Зоркальцева Е.Ю., Огарков О.Б. Изучение особенностей полиморфизма генов DC-SIGN-336A/G, MCP1-2518A/G, INFy +874A/T и конституциональных типов у детей с туберкулезной инфекцией // Acta Biomedica Scientifica. 2011. Т. 78, № 2. С. 198-200.
3. Малышев И.Ю., Лямина С.В., Шимшелашвили Ш.Л., Вассерман Е.Н. Функциональные ответы альвеолярных макрофагов, сурфактантный белок D и заболевания легких // Пульмонология. 2014. № 3. С. 101-107.
4. Синьков В.В., Огарков О.Б., Зоркальцева Е.Ю., Скворцова Р.Г., Савилов Е.Д., Воробьева Д.В., Корчина С.И., Жданов С.Н., Косенкова Д.В., Медведева Т.В. Полиморфизм генов DC-SIGN —336A/G, MCP1 —2518A/G, IFNy +874A/T у больных легочным туберкулезом в Иркутской области // Сибирский медицинский журнал. 2009. Т. 90, № 7. С. 30—33.
5. Astarie-Dequeker C., Le Guyader L., Malaga W., Seaphanh F.-K., Chalut C., Lopez A., Guilhot C. Phthiocerol dimycocerosates of M. tuberculosis participate in macrophage invasion by inducing changes in the organization of plasma membrane lipids. PLoS Pathog., 2009, vol. 5, no. 2: e1000289. doi: 10.1371/journal.ppat.1000289
6. Astarie-Dequeker C., N’Diaye E.N., Cabec V.Le, Rittig M.G., Prandi J., Maridonneau-Parini I. The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages. Infect. Immun., 1999, vol. 67, no. 2, pp. 469—477.
7. Azad A.K., Sadee W., Schlesinger L.S. Innate immune gene polymorphisms in tuberculosis. Infect. Immun., 2012, vol. 80, no. 10, pp. 3343-3359. doi: 10.1128/IAI.00443-12
8. Azad A.K., Torrelles J.B., Schlesinger L.S. Mutation in the DC-SIGN cytoplasmic triacidic cluster motif markedly attenuates receptor activity for phagocytosis and endocytosis of mannose-containing ligands by human myeloid cells. J. Leukoc. Biol., 2008, vol. 84, no. 6, pp. 1594-1603. doi: 10.1189/jlb.0308192
9. Bandyopadhyay U., Chadha A., Gupta P., Tiwari B., Bhattacharyya K., Popli S., Raman R., Brahamachari V., Singh Y., Malhotra P., Natarajan K. Suppression of Toll-like receptor 2—mediated proinflammatory responses by Mycobacterium tuberculosis protein Rv3529c. J. Leukoc. Biol., 2017, vol. 102, no. 5,pp. 1249-1259. doi: 10.1189/jlb.4A0217-042R
10. Bao M., Yi Z., Fu Y. Activation of TLR7 inhibition of Mycobacterium tuberculosis survival by autophagy in RAW 264.7 macrophages. J. Cell. Biochem., 2017, vol. 118, no. 12, pp. 4222-4229. doi: 10.1002/jcb.26072
11. Barreiro L.B., Neyrolles O., Babb C.L., Tailleux L., Quach H., McElreavey K., Helden P.D. Van, Hoal E.G., Gicquel B., Quintana-Murci L. Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoSMed., 2006, vol. 3, no. 2: e20. doi: 10.1371/journal.pmed.0030020
12. Beharka A.A., Gaynor C.D., Kang B.K., Voelker D.R., McCormack F.X., Schlesinger L.S. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J. immunol., 2002, vol. 169, no. 7,pp. 3565-3573. doi: 10.4049/jimmunol.169.7.3565
13. Ben-Ali M., Barbouche M.-R., Bousnina S., Chabbou A., Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagnost. Lab. Immunol., 2004, vol. 11, no. 3, pp. 625-626. doi: 10.1128/CDLI.11.3.625-626.2004
14. Bharti D., Kumar A., Mahla R.S., Kumar S., Ingle H., Shankar H., Joshi B., Raut A.A., Kumar H. The role ofTLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics, 2014, vol. 66, no. 12,pp. 675-681. doi: 10.1007/s00251-014-0806-1
15. Boily-Larouche G., Zijenah L.S., Mbizvo M., Ward B.J., Roger M. DC-SIGN and DC-SIGNR genetic diversity among different ethnic populations: Potential implications for pathogen recognition and disease susceptibility. Hum. Immunol., 2007, vol. 68, no. 6, pp. 523-530. doi: 10.1016/j.humimm.2007.02.002
16. Bowdish D.M.E., Sakamoto K., Kim M., Kroos M., Mukhopadhyay S., Leifer C.A., Tryggvason K., Gordon S., Russell D.G. MARCO, TLR2, and CD 14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog., 2009, vol. 5, no. 6: e1000474. doi: 10.1371/journal.ppat.1000474
17. Brooks M.N., Rajaram M.V.S., Azad A.K., Amer A.O., Valdivia-arenas M.A., Park J., Nunez G., Schlesinger L.S. NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cell. Microbiol, 2010, vol. 13, no. 3,pp. 402-418. doi: 10.1111/j.1462-5822.2010.01544.x
18. Capparelli R., Iannaccone M., Palumbo D., Medaglia C., Moscariello E., Russo A., Iannelli D. Role played by human mannosebinding lectin polymorphisms in pulmonary tuberculosis. J. Infect. Dis., 2009, vol. 199, no. 5, pp. 666- 672. doi: 10.1086/596658
19. Ceylan E., Karkucak M., Coban H., Karadag M., Yakut T. Evaluation of TNF-alpha gene (G308A) and MBL2 gene codon 54 polymorphisms in Turkish patients with tuberculosis. J. Infect. Public Health, 2017, vol. 10, no. 6, pp. 774-777. doi: 10.1016/j.jiph.2016.11.003
20. Chieppa M., Bianchi G., Doni A., Prete A., Del, Sironi M., Laskarin G., Monti P., Piemonti L., Biondi A., Mantovani A., Introna M., Allavena P. Cross-linking of the mannose receptor on monocyte-derived dendriticcells activates an anti-inflammatory immunosuppressive program. J. Immunol., 2003, vol. 171, no. 9, pp. 4552-4560. doi: 10.4049/jimmunol.171.9.4552
21. Chroneos Z.C., Midde K., Sever-Chroneos Z., Jagannath C. Pulmonary surfactant and tuberculosis. Tuberculosis, 2009, vol. 89, suppl. 1, pp. S10-14. doi: 10.1016/S1472-9792(09)70005-8
22. Chua J., Vergne I., Master S., Deretic V. A tale of two lipids: Mycobacterium tuberculosis phagosome maturation arrest. Curr. Opin. Microbiol., 2004, vol. 7, no. 1, pp. 71-77. doi: 10.1016/j.mib.2003.12.011
23. Coulombe F., Divangahi M., Veyrier F., Leseleuc L. De, Gleason J.L., Yang Y., Kelliher M.A., Pandey A.K., Sassetti C.M., Reed M.B., Behr M.A. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J. Exp. Med., 2009, vol. 206, no. 8, pp. 1-8. doi: 10.1084/jem.20081779
24. Court N., Vasseur V., Vacher R., Fremond C., Shebzukhov Y., Yeremeev V.V., Maillet I., Nedospasov S.A., Gordon S., Fallon P.G., Suzuki H., Ryffel B., Quesniaux V.F.J. Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection. J. Immunol., 2010, vol. 184, no. 12, pp. 7057-7070. doi: 10.4049/jimmunol.1000164
25. Dalgic N., Tekin D., Kayaalti Z., Soylemezoglu T., Cakir E., Kilic B., Kutlubay B., Sancar M., Odabasi M. Arg753Gln polymorphism of the human Toll-like receptor 2 gene from infection to disease in pediatric tuberculosis. Hum. Immunol., 2011, vol. 72, no. 5, pp. 440-445. doi: 10.1016/j.hummim.2011.02.001
26. De Oliveira L.R., Peresi E., Golim Mde A., Gatto M., Araujo Junior J.P., da Costa E.A., Ayres J.A., Fortes M.R., Calvi S.A. Analysis of Toll-like receptors, iNOS and cytokine profiles in patients with pulmonary tuberculosis during anti-tuberculosis treatment. PLoS One, 2014, vol. 9, no. 2: e88572. doi: 10.1371/journal.pone.0088572
27. DeFife K.M., Jenney C.R., McNally A.K., Colton E., Anderson J.M. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J. Immunol., 1997, vol. 158, no. 7, pp. 3385-3390.
28. Dodd C.E., Pyle C.J., Glowinski R., Rajaram M.V.S., Schlesinger L.S. CD36-mediated uptake of surfactant lipids by human macrophages promotes intracellular growth of Mycobacterium tuberculosis. J. Immunol., 2016, vol. 197, no. 12, pp. 4727-4735. doi: 10.4049/jimmunol.1600856
29. Enomoto Y., Hagiwara E., Komatsu S., Nishihira R., Baba T., Ogura T. Comparison of biomarkers of pulmonary tuberculosis activity — serum surfactant proteins A and D, KL-6, C-reactive protein, and erythrocyte sedimentation rate. Kekkaku: [Tuberculosis]., 2014, vol. 89, no. 7, pp. 637—642.
30. Ferguson J.S., Martin J.L., Azad A.K., McCarthy T.R., Kang P.B., Voelker D.R., Crouch E.C., Schlesinger L.S. Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infect. Immun., 2006, vol. 74, no. 12,pp. 7005- 7009. doi: 10.1128/IAI.01402-06
31. Figdor C.G., Kooyk van Y., Adema G.J. C-type lectin receptors on dendritic cells and langerhans cells. Nat. Rev. Immunol., 2002, vol. 2, no. 2, pp. 77-84. doi: 10.1038/nri723
32. Floras J., Lin H., Garcia A., Salazar M.A., Guo X., DiAngelo S., Montano M., Luo J., Pardo A., Selman M. Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in a Mexican population. J. Infect. Dis., 2000, vol. 182, no. 5, pp. 1473—1478. doi: 10.1086/315866
33. Fratti R.A., Chua J., Vergne I., Deretic V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Nati. Acad. Sci. USA, 2003, vol. 100, no. 9, pp. 5437—5442. doi: 10.1073/pnas.0737613100
34. Fremond C.M., Yeremeev V., Nicolle D.M., Jacobs M., Quesniaux V.F., Ryffel B. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest., 2004, vol. 114, no. 12, pp. 1790—1799. doi: 10.1172/JCI21027
35. Garred P., Richter C., Andersen A.B., Madsen H.O., Mtoni I., Svejgaard A., Shao J. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand. J. Immunol., 1997, vol. 46, no. 2, pp. 204—208.
36. Geijtenbeek T.B.H., Vliet S.J. van, Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M.J.E., Appelmelk B., Kooyk van Y. Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function. J. Exp. Med., 2003, vol. 197, no. 1, pp. 7—17. doi: 10.1084/jem.20021229
37. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science, 2010, vol. 327, no. 5966,pp. 656— 661. doi: 10.1126/science.1178331
38. Gomez L.M., Anaya J.M., Sierra-Filardi E., Cadena J., Corbi A., Martin J. Analysis of DC-SIGN (CD209) Functional variants in patients with tuberculosis. Hum. Immunol., 2006, vol. 67, no. 10, pp. 808—811. doi: 10.1016/j.humimm.2006.07.003
39. Gupta D., Sharma S., Singhal J., Satsangi A.T., Antony C., Natarajan K. Suppression of TLR2-induced IL-12, reactive oxygen species, and inducible nitric oxide synthase expression by Mycobacterium tuberculosis antigens expressed inside macrophages during the course of infection. J. Immunol, 2010, vol. 184, no. 10, pp. 5444—5455. doi: 10.4049/jimmunol.0903283
40. Guzel A., Karadag A., Okuyucu A., Alacam H., Kucuk Y. The evaluation of serum surfactant protein D (SP-D) levels as a biomarker of lung injury in tuberculosis and different lung diseases. Clin. Lab., 2014, vol. 60, no. 7, pp. 1091—1098.
41. Harding C.V., Boom W.H. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat. Rev. Microbiol., 2010, vol. 8, no. 4, pp. 296—307. doi: 10.1038/nrmicro2321
42. Harriff M.J., Cansler M.E., Toren K.G., Canfield E.T., Kwak S., Gold M.C., Lewinsohn D.M. Human lung epithelial cells contain Mycobacterium tuberculosis in a late endosomal vacuole and are efficiently recognized by CD8+ T cells. PLoS One, 2014, vol. 9, no. 5: e97515. doi: 10.1371/journal.pone.0097515
43. Hartel C., Rupp J., Hoegemann A., Bohler A., Spiegler J., Otte S. Von, Roder K., Schultz C., Gopel W. 159C > T CD14 genotype — Functional effects on innate immune responses in term neonates. Hum. Immunol., 2008, pp. 338—343. doi: 10.1016/j.humimm.2008.04.011
44. Hawkes M., Li X., Crockett M., Diassiti A., Finney C., Min-Oo G., Liles W.C., Liu J., Kain K.C. CD36 deficiency attenuates experimental mycobacterial infection. BMC Infect. Dis., 2010, vol. 10:299. doi: 10.1186/1471-2334-10-299
45. Heldwein K.A., Fenton M.J. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect., 2002, vol. 4, no. 9, pp. 937-944. doi: 10.1016/S1286-4579(02)01611-8
46. Henning L.N., Azad A.K., Parsa K.V.L., Crowther J.E., Tridandapani S., Schlesinger L.S. Pulmonary surfactant protein a regulates TLR expression and activity in human macrophages. J. Immunol., 2008, vol. 180, no. 2, pp. 7847-7858. doi: 10.4049/jim-munol.180.12.7847
47. Hsieh M.H., Ou C.Y., Hsieh W.Y., Kao H.F., Lee S.W., Wang J., Wu L.S.H. Functional analysis of genetic variations in surfactant protein D in Mycobacterial infection and their association with tuberculosis. Front. Immunol., 2018, vol. 9. doi: 10.3389/fimmu.2018.01543
48. Jo E.K. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Curr. Opin. Infect. Dis., 2008, vol. 21, no. 3,pp. 279-286. doi: 10.1097/QCO.0b013e3282f88b5d
49. Jo E.K., Yang C.S., Choi C.H., Harding C .V. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: bzzzranching out from Toll-like receptors. Cell. Microbiol., 2007, vol. 9, no. 5, pp. 1087-1098. doi: 10.1111/j.1462-5822.2007.00914.x
50. Kang P.B., Azad A.K., Torrelles J.B., Kaufman T.M., Beharka A., Tibesar E., DesJardin L.E., Schlesinger L.S. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med, 2005, vol. 202, no. 7, pp. 987-999. doi: 10.1084/jem.20051239
51. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol., 2010, vol. 11, no. 5, pp. 373-384. doi: 10.1038/ni.1863
52. Khan A., Mann L., Papanna R., Lyu M.-A., Singh C.R., Olson S., Eissa N.T., Cirillo J., Das G., Hunter R.L., Jagannath C. Mesenchymal stem cells internalize Mycobacterium tuberculosis through scavenger receptors and restrict bacterial growth through autophagy. Sci. Rep., 2017, vol. 7, no. 1. doi: 10.1038/s41598-017-15290-z
53. Khan N., Pahari S., Vidyarthi A., Aqdas M., Agrewala J.N. NOD-2 and TLR4 signaling reinforces the efficacy of dendritic cells and reduces the dose of TB drugs against Mycobacterium tuberculosis. J. Innate Immun., 2016, vol. 8, no. 3, pp. 228-242. doi: 10.1159/000439591
54. Konowich J., Gopalakrishnan A., Dietzold J., Verma S., Bhatt K., Rafi W., Salgame P. Divergent functions of TLR2 on hematopoietic and nonhematopoietic cells during chronic Mycobacterium tuberculosis infection. J. Immunol., 2016, vol. 198, no. 2, pp. 741-748. doi: 10.4049/jimmunol.1601651
55. Kusner D.J. Mechanisms of mycobacterial persistence in tuberculosis. Clin. Immunol., 2005, vol. 114, no. 3, pp. 239-247. doi: 10.1016/j.clim .2004.07.016
56. Lee J.Y., Hwang E.H., Kim D.J., Oh S.M., Lee K.B., Shin S.J., Park J.H. The role of nucleotide-binding oligomerization domain 1 during cytokine production by macrophages in response to Mycobacterium tuberculosis infection. Immunobiology, 2016, vol. 221, no. 1,pp. 70-75. doi: 10.1016/j.imbio.2015.07.020
57. Lee M.S., Kim Y.J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem., 2007, vol. 76,pp. 447-480. doi: 10.1146/annurev.biochem.76.060605.122847
58. Li Y., Wang Y., Liu X. The role of airway epithelial cells in response to mycobacteria infection. Clin. Dev. Immunol., 2012, vol. 2012. doi: 10.1155/2012/791392
59. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A., Zugel U., Gallo R.L, Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom B.R., Modlin R.L.Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 2006, vol. 311, no. 5768, pp. 1770-1773. doi: 10.1126/science.1123933
60. Lugo-Villarino G., Hudrisier D., Tanne A., Neyrolles O. C-type lectins with a sweet spot for Mycobacterium tuberculosis. Eur. J. Microbiol. Immunol., 2011, vol. 1, no. 1, pp. 25-40. doi: 10.1556/EuJMI. 1.2011.1.6
61. Lugo-Villarino G., Troegeler A., Balboa L., Lastrucci C., Duval C., Mercier I., Benard A., Capilla F., Saati T. Al, Poincloux R., Kondova I., Verreck F.A.W., Cougoule C., Maridonneau-Parini I., Sasiain M.D.C., Neyrolles O. The C-type lectin receptor DC-SIGN has an anti-inflammatory role in human M(IL-4) macrophages in response to Mycobacterium tuberculosis. Front. Immunol., 2018, vol. 9:1123. doi: 10.3389/fimmu.2018.01123
62. Lv J., He X., Wang H., Wang Z., Kelly G.T., Wang X., Chen Y., Wang T., Qian Z. TLR4-NOX2 axis regulates the phagocytosis and killing of Mycobacterium tuberculosis by macrophages. BMCPulm. Med., 2017, vol. 17, no. 1,p. 194. doi: 10.1186/s12890-017-0517-0
63. Maes E., Coddeville B., Kremer L., Guerardel Y. Polysaccharide structural variability in mycobacteria: Identification and characterization of phosphorylated mannan and arabinomannan. Glycoconj. J., 2007, vol. 24, no. 8, pp. 439- 448. doi: 10.1007/s10719-007-9036-1
64. Malik S., Greenwood C.M.T., Eguale T., Kifle A., Beyene J., Habte A., Tadesse A., Gebrexabher H., Britton S., Schurr E. Variants of the SFTPA1 and SFTPA2 genes and susceptibility to tuberculosis in Ethiopia. Hum. Genet., 2006, vol. 118, no. 6, pp. 752-759. doi: 10.1007/s00439-005-0092-y
65. Martinez-Pomares L., Reid D.M., Brown G.D., Taylor P.R., Stillion R.J., Linehan S.A., Zamze S., Gordon S., Wong S.Y.C. Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies. J. Leukocyte Biol, 2003, vol. 73, no. 5,pp. 604- 613. doi: 10.1189/jlb.0902450
66. Matsushita M., Endo Y., Fujita T. Structural and functional overview of the lectin complement pathway: Its molecular basis and physiological implication. Arch. Immunol. Ther. Exp, 2013, vol. 61, no. 4,pp. 273-283. doi: 10.1007/s00005-013-0229-y
67. McBride A., Konowich J., Salgame P. Host defense and recruitment of Foxp3+ T regulatory cells to the lungs in chronic mycobacterium tuberculosis infection requires Toll-like receptor 2. PLoS Pathog, 2013, vol. 9, no. 6: e1003397. doi: 10.1371/journal.ppat.1003397
68. McGreal E.P., Miller J.L., Gordon S. Ligand recognition by antigen-presenting cell C-type lectin receptors. Curr. Opin. Immunol., 2005, vol. 17, no. 1,pp. 18-24. doi: 10.1016/j.coi.2004.12.001
69. Mishra A.K., Driessen N.N., Appelmelk B.J., Besra G.S. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol. Rev., 2011, vol. 35, no. 6, pp. 1126-1157
70. Mittal M., Biswas S.K., Singh V., Arela N., Katoch V.M., Das R., Yadav V.S., Bajaj B., Mohanty K.K. Association of Toll like receptor 2 and 9 gene variants with pulmonary tuberculosis: exploration in a northern Indian population. Mol. Biol. Rep., 2018, vol. 45, no. 4, pp. 469-476. doi: 10.1007/s11033-018-4182-z
71. Nair V.R., Franco L.H., Zacharia V.M., Khan H.S., Stamm C.E., You W., Marciano D.K., Yagita H., Levine B., Shiloh M.U. Microfold cells actively translocate Mycobacterium tuberculosis to initiate infection. Cell Rep., 2016, vol. 16, no. 5, pp. 1253-1258. doi: 10.1016/j.celrep.2016.06.080
72. Nigou J., Zelle-Rieser C., Gilleron M., Thurnher M., Puzo G. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol., 2001, vol. 166, no. 12, pp. 7477-7485. doi: 10.4049/jimmunol.166.12.7477
73. Pattison M.J., Mitchell O., Flynn H.R., Chen C.-S., Yang H.-T., Ben-Addi H., Boeing S., Snijders A.P., Ley S.C. TLR and TNF-R1 activation of the MKK3/MKK6-p38a axis in macrophages is mediated by TPL-2 kinase. Biochem. J, 2016, vol. 473, no. 18, pp. 2845-2861. doi: 10.1042/BCJ20160502
74. Peterson P.K., Gekker G., Hu S., Sheng W.S., Anderson W.R., Ulevitch R.J., Tobias P.S., Gustafson K.V., Molitor T.W., Chao C.C. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun., 1995, vol. 63, no. 4, pp. 1598-1602
75. Platz J., Beisswenger C., Dalpke A., Koczulla R., Pinkenburg O., Vogelmeier C., Bals R. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J. Immunol., 2004, vol. 173, no. 2, pp. 1219-1223. doi: 10.4049/jimmunol.173.2.1219
76. Prabha C., Rajashree P., Sulochana D.D. TLR2 and TLR4 expression on the immune cells of tuberculous pleural fluid. Immunol. Lett., 2008, vol. 117, no. 1, pp. 26-34. doi: 10.1016/j.imlet.2007.11.002
77. Poyhonen L., Kroger L., Huhtala H., Makinen J., Nuolivirta K., Mertsola J., He Q., Korppi M. Association of MBL2, TLR1, TLR2 and TLR6 polymorphisms with production of IFN-y and IL-12 in BCG osteitis survivors R1. Pediatr. Infect. Dis. J, 2017, vol. 36, no. 2,pp. 135-139. doi: 10.1097/INF.0000000000001375
78. Queiroz A., Riley L.W. Bacterial immunostat: Mycobacterium tuberculosis lipids and their role in the host immune response. Rev. Soc. Bras. Med. Trop, 2017, vol. 50, no. 1,pp. 9-18. doi: 10.1590/0037-8682-0230-2016
79. Quesniaux V., Fremond C., Jacobs M., Parida S., Nicolle D., Yeremeev V., Bihl F., Erard F., Botha T., Drennan M., Soler M.N., Le Bert M., Schnyder B., Ryffel B. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect., 2004, vol. 6, no. 10, pp. 946-959. doi: 10.1016/j.micinf.2004.04.016
80. Ramakrishna K., Premkumar K., Kabeerdoss J., John K.R. Impaired toll like receptor 9 response in pulmonary tuberculosis. Cytokine, 2017, vol. 90, pp. 38-43. doi: 10.1016/j.cyto.2016.10.006
81. Richardson E.T., Shukla S., Sweet D.R., Wearsch P.A., Tsichlis P.N., Boom W.H., Harding C. V. Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells. Infect. Immun., 2015, vol. 83, no. 6, pp. 2242-2254. doi: 10.1128/iai.00135-15
82. Rivas-Santiago B., Contreras J.C.L., Sada E., Hernandez-Pando R. The potential role of lung epithelial cells and P-defensins in experimental latent tuberculosis. Scand. J. Immunol., 2008, vol. 67, no. 5, pp. 448-452. doi: 10.1111/j.1365-3083.2008.02088.x
83. Rivas-Santiago B., Hernandez-Pando R., Carranza C., Juarez E., Contreras J.L., Aguilar-Leon D., Torres M., Sada E. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect. Immun., 2008, vol. 76, no. 3, pp. 935—941. doi: 10.1128/IAI.01218-07
84. Rocha-Ramfrez L.M., Estrada-Garcfa I., Lopez-Marfn L.M., Segura-Salinas E., Mendez-Aragon P., Soolingen D. Van, Torres-Gonzalez R., Chacon-Salinas R., Estrada-Parra S., Maldonado-Bernal C., Lopez-Macfas C., Isibasi A. Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis, 2008, vol. 88, no. 3, pp. 212-220. doi: 10.1016/J.TUBE.2007.10.003
85. Rothfuchs A.G., Bafica A., Feng C.G., Egen J.G., Williams D.L., Brown G.D., Sher A. Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J. Immunol., 2007, vol. 179, no. 6, pp. 3463-3471. doi: 10.4049/jimmunol.179.6.3463
86. Saavedra R., Segura E., Leyva R., Esparza L.A., Lopez-Marfn L.M. Mycobacterial di-O-acyl-trehalose inhibits mitogen-and antigen-induced proliferation of murine T cells in vitro. Clin. Diagn. Lab. Immunol., 2001, vol. 8, no. 6, pp. 1081-1088. doi: 10.1128/CDLI.8.6.1-91-1088.2001
87. Sakamoto K., Kim M.J., Rhoades E.R., Allavena R.E., Ehrt S., Wainwright H.C., Russell D.G., Rohde K.H. Mycobacterial trehalose dimycolate reprograms macrophage global gene expression and activates matrix metalloproteinases. Infect. Immun., 2013, vol. 81, no. 3,pp. 764-776. doi: 10.1128/IAI.00906-12
88. Schlesinger L.S., Azad A.K., Torrelles J.B., Roberts E. Determinants of phagocytosis, phagosome biogenesis and autophagy for Mycobacterium tuberculosis. In: Handbook of tuberculosis. Immunology and cell biology. Eds: Kaufmann S.H.E., Britton W.J. Wiley-VCH Verlag; Weinheim, Germany: 2008. pp. 1-22.
89. Schlesinger L., Torrelles J., Azad A., Henning L., Carlson T. Role of C-type lectins in Mycobacterial infections. Curr. Drug Targets, 2008, vol. 9, no. 2, pp. 102-112. doi: 10.2174/138945008783502467
90. Schurz H., Daya M., Moller M., Hoal E.G., Salie M. TLR1, 2, 4, 6 and 9 variants associated with tuberculosis susceptibility: a systematic review and meta-analysis. PLoS One, 2015, vol. 10, no. 10: e0139711. doi: 10.1371/journal.pone.0139711
91. Selvaraj P., Jawahar M.S., Rajeswari D.N., Alagarasu K., Vidyarani M., Narayanan P.R. Role of mannose binding lectin gene variants on its protein levels and macrophage phagocytosis with live Mycobacterium tuberculosis in pulmonary tuberculosis. FEMS Immunol. Med. Microbiol., 2006, vol. 46, no. 3,pp. 433-437. doi: 10.1111/j.1574-695X.2006.00053.x
92. Sepehri Z., Kiani Z., Kohan F., Ghavami S. Toll-like receptor 4 as an immune receptor against Mycobacterium tuberculosis: a systematic review. Lab. Med., 2018. doi: 10.1093/labmed/lmy047
93. Sequeira P.C., Senaratne R.H., Riley L.W. Inhibition of toll-like receptor 2 (TLR-2)-mediated response in human alveolar epithelial cells by mycolic acids and Mycobacterium tuberculosis mce1 operon mutant. Pathog. Dis., 2014, vol. 70, no. 2, pp. 132-140. doi: 10.1111/2049-632X.12110
94. Sever-Chroneos Z., Tvinnereim A., Hunter R.L., Chroneos Z.C. Prolonged survival of scavenger receptor class A-deficient mice from pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb.), 2011, vol. 91, suppl. 1, pp. S69-S74. doi: 10.1016/j.tube.2011.10.014
95. Shin D.M., Yuk J.M., Lee H.M., Lee S.H., Son J.W., Harding C. V., Kim J.M., Modlin R.L., Jo E.K. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell. Microbiol., 2010, vol. 12, no. 11, pp. 1648-1665. doi: 10.1111/j.1462-5822.2010.01497.x
96. Soeroto A.Y., Dahlan Z., Kartasasmita C.B., Parwati I. Association between Arg753Gln and Arg677Trp polymorphisms of TLR2 gene with active pulmonary tuberculosis in an indonesian population. Acta Med. Indones., 2018, vol. 50, no. 1, pp. 53—60.
97. Sorensen G.L. Surfactant protein D in respiratory and non-respiratory diseases. Front. Med., 2018, vol. 5, no. 18. doi: 10.3389/fmed.2018.00018
98. Srivastava V., Manchanda M., Gupta S., Singla R., Behera D., Das G., Natarajan K. Toll-like receptor 2 and DC-SIGNR1 differentially regulate suppressors of cytokine signaling 1 in dendritic cells during Mycobacterium tuberculosis infection. J. Biol. Chem., 2009, vol. 284, no. 38,pp. 25532-25541. doi: 10.1074/jbc.M109.006221
99. Suzuki T., Chow C., Downey G.P. Role of innate immune cells and their products in lung immunopathology. Int. J. Biochem. Cell Biol, 2008, vol. 40, no. 6-7, pp. 1348-1361. doi: 10.1016/j.biocel.2008.01.003
100. Soborg C., Madsen H.O., Andersen A.B., Lillebaek T., Kok-Jensen A., Garred P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J. Infect. Dis., 2003, vol. 188, no. 5, pp. 777-782. doi: 10.1086/377183
101. Tailleux L., Pham-Thi N., Bergeron-Lafaurie A., Herrmann J.L., Charles P., Schwartz O., Scheinmann P., Lagrange P.H., De Blic J., Tazi A., Gicquel B., Neyrolles O. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis. PLoS Med, 2005, vol. 2, no. 12, pp. 1269-1279. doi: 10.1371/journal.pmed.0020381
102. Tailleux L., Schwartz O., Herrmann J.-L., Pivert E., Jackson M., Amara A., Legres L., Dreher D., Nicod L.P., Gluckman J.C., Lagrange P.H., Gicquel B., Neyrolles O. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med, 2003, vol. 197, no. 1, pp. 121-127. doi: 10.1084/jem.20021468
103. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol., 2002, vol. 169, no. 1, pp. 10-14. doi: 10.4049/jimmu-nol.169.1.10
104. Torrelles J.B., Azad A.K., Schlesinger L.S. Fine discrimination in the recognition of individual species of phosphatidyl-myoinositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J. Immunol., 2006, vol. 177, no. 3, pp. 1805-1816. doi: 10.4049/jimmunol.177.3.1805
105. Udgata A., Qureshi R., Mukhopadhyay S. Transduction of functionally contrasting signals by two mycobacterial PPE proteins downstream of TLR2 receptors. J. Immunol., 2016, vol. 197, no. 5, pp. 1776-1787. doi: 10.4049/jimmunol.1501816
106. Van der Veerdonk F.L., Teirlinck A.C., Kleinnijenhuis J., Kullberg B.J., van Crevel R., van der Meer J.W.M., Joosten L.A.B., Netea M.G. Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. J. Leukoc. Biol., 2010, vol. 88, no. 2, pp. 227-232. doi: 10.1189/jlb.0809550
107. Villeneuve C., Gilleron M., Maridonneau-Parini I., Daffe M., Astarie-Dequeker C., Etienne G. Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process. J. Lipid Res., 2005, vol. 46, no. 3, pp. 475-483. doi: 10.1194/jlr.M400308-JLR200
108. Wieland C.W., van der Windt G.J.W., Wiersinga W.J., Florquin S., van der Poll T. CD14 contributes to pulmonary inflammation and mortality during murine tuberculosis. Immunology, 2008, vol. 125, no. 2, pp. 272-279. doi: 10.1111/j.1365-2567.2008.02840.x
109. Wright J.R. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol., 2005, vol. 5, no. 1, pp. 58- 68. doi: 10.1038/nri1528
110. Wu S., Huang W., Wang D., Wang Y., Wang M., Zhang M., He J.-Q. Evaluation of TLR 2, TLR 4, and TOLLIP polymorphisms for their role in tuberculosis susceptibility. Apmis, 2018, vol. 126, no. 6, pp. 501-508. doi: 10.1111/apm.12855
111. Xu Q., Jin M.M., Zheng W.W., Zhu L., Xu S.L. Role of Toll-like receptor 2/4-nuclear factor-KB signaling pathway in invasion of Mycobacterium tuberculosis to mouse dendritic cells. Zhejiang Da Xue Xue Bao Yi Xue Ban, 2014, vol. 43, no. 2, pp. 200-206.
112. Xue Y., Zhao Z.Q., Chen F., Zhang L., Li G.D., Ma K.W., Bai X.F., Zuo Y.J. Polymorphisms in the promoter of the CD14 gene and their associations with susceptibility to pulmonary tuberculosis. Tissue Antigens, 2012, vol. 80, no. 5, pp. 437-443. doi: 10.1111/j.1399-0039.2012.01958.x
113. Yadav M., Schorey J.S. The P-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood, 2006, vol. 108, no. 9, pp. 3168-3175. doi: 10.1182/blood-2006-05-024406
114. Yang C.-S., Shin D.-M., Kim K.-H., Lee Z.-W., Lee C.-H., Park S.G., Bae Y.S., Jo E.-K. NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. J. Immunol., 2009, vol. 182, no. 6, pp. 3696-705. doi: 10.4049/jimmunol.0802217
115. Yang Y., Kulka K., Montelaro R.C., Reinhart T.A., Sissons J., Aderem A., Ojha A.K. A hydrolase of trehalose dimycolate induces nutrient influx and stress sensitivity to balance intracellular growth of Mycobacterium tuberculosis. Cell Host Microbe, 2014, vol. 15, no. 2, pp. 153-163. doi: 10.1016/j.chom.2014.01.008
116. Zenaro E., Donini M., Dusi S. Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, mannose receptor, and DC-SIGN. J. Leukoc. Biol., 2009, vol. 86, no. 6, pp. 1393-1401. doi: 10.1189/jlb.0409242
117. Zhao L., Liu K., Kong X., Tao Z., Wang Y., Liu Y. Association of polymorphisms in Toll-like receptors 4 and 9 with risk of pulmonary tuberculosis: a meta-analysis. Med. Sci. Monit., 2015, vol. 21, pp. 1097-1106. doi: 10.12659/MSM.893755
118. Zimmermann N., Saiga H., Houthuys E., Moura-Alves P., Koehler A., Bandermann S., Dorhoi A., Kaufmann S.H.E. Syndecans promote mycobacterial internalization by lung epithelial cells. Cell. Microbiol., 2016, vol. 18, no. 12, pp. 1846-1856. doi: 10.1111/cmi.12627z
Дополнительные файлы
Для цитирования:
Лапштаева А.В., Живечкова Е.А., Сычев И.В., Евсегнеева И.В., Новиков В.В. Роль рецепторов врожденного иммунитета в развитии инфекционного процесса, обусловленного Mycobacterium tuberculosis. Инфекция и иммунитет. 2020;10(1):35-48. https://doi.org/10.15789/2220-7619-ROI-1169
For citation:
Lapshtaeva A.V., Zhivechkova E.A., Sychev I.V., Evsegneeva I.V., Novikov V.V. Innate immune receptors in development of Mycobacterium tuberculosis infection. Russian Journal of Infection and Immunity. 2020;10(1):35-48. (In Russ.) https://doi.org/10.15789/2220-7619-ROI-1169